Browsing Tag
Vivo Capital
2 posts
Reynold Lemkins Group expands cross-border biotech investments with VISEN Pharmaceuticals (HKEX: 02561) IPO
Reynold Lemkins Group expands cross-border biotech strategy with VISEN Pharmaceuticals (HKEX: 02561) IPO, aligning capital with Asia’s AI-driven healthcare future.
June 10, 2025
ALX Oncology raises $105m to advance clinical development of ALX148
ALX Oncology, a clinical-stage immuno-oncology company based in California, has raised $105 million in a Series C equity…
February 14, 2020